Maternal Thyroid Disorders and Risk of Autism Spectrum Disorder in Progeny
- PMID: 32251066
- DOI: 10.1097/EDE.0000000000001174
Maternal Thyroid Disorders and Risk of Autism Spectrum Disorder in Progeny
Abstract
Background: Maternal thyroid dysfunction is suspected of causing adverse neurodevelopmental effects, but current evidence is inconclusive. Epidemiologic investigations generally suggest an association between maternal thyroid dysfunction and neurodevelopment impairments in progeny, but clinical trials of thyroid treatment during pregnancy reported null effects. To better understand these discrepant findings, we evaluated the association between maternal thyroid conditions and autism spectrum disorder (ASD), including examining the role of gestational thyroid-related hormone concentrations and thyroid medications use.
Methods: Analyses considered 437,222 singleton live births occurring in a large Israeli health fund in 1999-2013, followed through 2016. Thyroid conditions and ASD cases were identified through International Classification of Diseases-9 codes with subsequent validation through review of medical records. Laboratory gestational thyroid hormone measurements were also considered.
Results: Children of mothers who ever experienced hypothyroidism had a higher risk of ASD compared with children of mothers without hypothyroidism (adjusted odds ratio [aOR] = 1.26, 95% confidence interval [CI] = 1.12, 1.42). The association with hyperthyroidism was less consistent, but elevated in main analyses (aOR = 1.42, 95% CI = 1.04, 1.94). These associations were not explained by maternal gestational thyroid hormones levels nor mitigated by gestational use of thyroid medications.
Conclusions: Results indicate that maternal thyroid conditions are associated with increased ASD risk in progeny, but suggestively not due to direct effects of thyroid hormones. Instead, factors that influence maternal thyroid function could have etiologic roles in ASD through pathways independent of maternal gestational thyroid hormones and thus be unaffected by medication treatment. Factors known to disrupt thyroid function should be examined for possible involvement in ASD etiology.
Similar articles
-
Maternal Thyroid Dysfunction During Pregnancy as an Etiologic Factor in Autism Spectrum Disorder: Challenges and Opportunities for Research.Thyroid. 2024 Feb;34(2):144-157. doi: 10.1089/thy.2023.0391. Epub 2024 Jan 22. Thyroid. 2024. PMID: 38149625 Review.
-
Maternal Thyroid Anomalies and Attention-Deficit Hyperactivity Disorder in Progeny.Am J Epidemiol. 2022 Feb 19;191(3):430-440. doi: 10.1093/aje/kwab272. Am J Epidemiol. 2022. PMID: 34791037 Free PMC article.
-
Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study.BJOG. 2014 Oct;121(11):1365-74. doi: 10.1111/1471-0528.12681. Epub 2014 Mar 10. BJOG. 2014. PMID: 24605987
-
Maternal Pre-pregnancy Body Mass Index and Gestational Weight Gain in Relation to Autism Spectrum Disorder and other Developmental Disorders in Offspring.Autism Res. 2019 Feb;12(2):316-327. doi: 10.1002/aur.2057. Epub 2018 Dec 21. Autism Res. 2019. PMID: 30575327 Free PMC article.
-
Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations.BMC Med. 2018 Jan 15;16(1):6. doi: 10.1186/s12916-017-0993-3. BMC Med. 2018. PMID: 29332605 Free PMC article. Review.
Cited by
-
Maternal Thyroid Dysfunction During Pregnancy as an Etiologic Factor in Autism Spectrum Disorder: Challenges and Opportunities for Research.Thyroid. 2024 Feb;34(2):144-157. doi: 10.1089/thy.2023.0391. Epub 2024 Jan 22. Thyroid. 2024. PMID: 38149625 Review.
-
Maternal Thyroid Function During Pregnancy and Offspring White Matter Microstructure in Early Adulthood: A Prospective Birth Cohort Study.Thyroid. 2023 Oct;33(10):1245-1254. doi: 10.1089/thy.2022.0699. Epub 2023 Aug 21. Thyroid. 2023. PMID: 37498774 Free PMC article.
-
Prenatal Exposure to Per- and Polyfluoroalkyl Substances, Maternal Thyroid Dysfunction, and Child Autism Spectrum Disorder.Endocrinol Metab (Seoul). 2022 Dec;37(6):819-829. doi: 10.3803/EnM.2022.1598. Epub 2022 Nov 23. Endocrinol Metab (Seoul). 2022. PMID: 36415960 Free PMC article. Review.
-
Associations of Hypothyroxinemia With Risk of Preeclampsia-Eclampsia and Gestational Hypertension.Front Endocrinol (Lausanne). 2021 Nov 4;12:777152. doi: 10.3389/fendo.2021.777152. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34803932 Free PMC article.
-
Systematic Review and Bioinformatic Analysis of microRNA Expression in Autism Spectrum Disorder Identifies Pathways Associated With Cancer, Metabolism, Cell Signaling, and Cell Adhesion.Front Psychiatry. 2021 Oct 21;12:630876. doi: 10.3389/fpsyt.2021.630876. eCollection 2021. Front Psychiatry. 2021. PMID: 34744804 Free PMC article.
References
-
- Lavado-Autric R, Ausó E, García-Velasco JV, et al. Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest. 2003;111:1073–1082.
-
- Moog NK, Entringer S, Heim C, Wadhwa PD, Kathmann N, Buss C. Influence of maternal thyroid hormones during gestation on fetal brain development. Neuroscience. 2017;342:68–100.
-
- Román GC, Ghassabian A, Bongers-Schokking JJ, et al. Association of gestational maternal hypothyroxinemia and increased autism risk. Ann Neurol. 2013;74:733–742.
-
- Andersen SL, Laurberg P, Wu CS, Olsen J. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study. BJOG. 2014;121:1365–1374.
-
- Andersen SL, Olsen J, Laurberg P. Foetal programming by maternal thyroid disease. Clin Endocrinol (Oxf). 2015;83:751–758.
